MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Metagenomi (MGX) Ownership - Who owns Metagenomi?
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more
Profile
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.77M
P/E Ratio
N/A
Total Cash
225.97M
Projected Growth
N/A
Total Debt
44.44M
Revenue
45.26M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.04
Total Debt/Equity
N/A
Revenue/Share
1.22 USD as % of share price
Fundamentals
MGX
Capitalization
71.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
226M
Total Cash/Share
6.04
Total Debt
44.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.22%
Revenue
45.3M
ROE
N/A
Book Value
213M
P/B Ratio
0.34
Cash Flow
N/A
Earnings
-1.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
5.85
Current Revenue Per Employee
23448.86
Dividends Per Share - Security
N/A
EBITDA
-82.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.86
Shares Held By Institutions
15.9M
Shares Outstanding - Current
37.4M
Total Liabilities
85.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.814
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MGX showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co